Alpha -Tocopherol Ascorbic Acid Banana Beta Carote
| Evidence Level: L5 | Predicted Indications: 0 |
Table of Contents
- Alpha -Tocopherol Ascorbic Acid Banana Beta Carote
- Multi-component Natural Supplement Formulation: Insufficient Assessment Data, Cannot Proceed with Drug Repurposing Analysis
Multi-component Natural Supplement Formulation: Insufficient Assessment Data, Cannot Proceed with Drug Repurposing Analysis
One-Sentence Summary
This candidate is a multi-component supplement formulation composed of eight natural ingredients (α-tocopherol, ascorbic acid, banana, β-carotene, Houttuynia cordata, inulin, nattokinase, rutin), not a single chemical drug, and has not obtained any drug license in Taiwan to date. The TxGNN model failed to generate any predicted indications, primarily because the multi-component formulation cannot be mapped to DrugBank knowledge graph nodes, compounded by the lack of DrugBank ID and original indication data; this assessment cannot proceed to substantive analysis phase.
Quick Overview
| Item | Content |
|---|---|
| Ingredient composition | α-tocopherol / ascorbic acid / banana / β-carotene / Houttuynia cordata / inulin / nattokinase / rutin |
| Original indication | No data |
| Predicted new indication | None (TxGNN unable to map; no prediction generated) |
| TxGNN prediction score | Not applicable |
| Evidence level | L5 (model prediction failed; no supporting actual research) |
| Taiwan market status | ✗ Not marketed (0 drug licenses) |
| Number of licenses | 0 |
| Recommended decision | Hold |
Why is This Prediction Reasonable?
This product is not a traditional single-entity drug, but rather a multi-component formulation composed of eight natural active substances from diverse sources:
- Antioxidant vitamins: α-tocopherol (vitamin E), ascorbic acid (vitamin C), β-carotene (vitamin A precursor), possessing properties for free radical scavenging and inhibition of oxidative stress.
- Phytochemicals: rutin (flavonoid with anti-inflammatory and vascular protective action), Houttuynia cordata (traditional herbal medicine with potential antimicrobial and immunomodulatory effects).
- Functional food ingredients: inulin (prebiotic fiber, modulates gut microbiota), banana (potassium source and carbohydrate), nattokinase (serine protease with fibrinolytic activity).
Because this product is a multi-component formulation and most of the ingredients are food or health food materials (not pharmaceutical drugs), the TxGNN knowledge graph—based on DrugBank drug nodes for network reasoning—cannot perform systematic mapping and prediction for such complex formulations.
Currently, the original_moa field is empty, precluding mechanistic association analysis. Should drug repurposing assessment be required, it is recommended to segregate each single ingredient as an independent candidate for separate evaluation (for example: independently assess the repositioning potential of Nattokinase or Rutin).
Clinical Trial Evidence
No relevant clinical trial registrations are currently available (TxGNN generated no predicted indications, hence no targeted queries could be performed).
Literature Evidence
No relevant literature is currently available (TxGNN generated no predicted indications, hence no targeted queries could be performed).
US Market Information
This product holds no drug license in Taiwan and has no corresponding US FDA drug license data to display.
Safety Considerations
Please refer to the individual product information sheets or safety data sheets of each ingredient for safety information.
Conclusion and Next Steps
Decision: Hold
Rationale: This product is a multi-component natural formulation without drug licenses in Taiwan, with failed TxGNN mapping and no predicted indications. Under current technical conditions, effective drug repurposing assessment cannot be performed; advancement is not recommended until clear designation of individual active ingredients and drug-grade data are obtained.
To proceed, the following is needed:
- Segregate candidate items: Establish independent Evidence Packs for each of the eight ingredients, entering the TxGNN mapping workflow as individual INNs (priority recommendation: Nattokinase, Rutin, Houttuynia cordata)
- Establish pharmaceutical identity: Confirm whether each ingredient has a corresponding DrugBank ID (currently, no DrugBank ID is found for the overall formulation)
- Supplement mechanism of action (MOA): Query DrugBank API for MOA data of each individual ingredient to resolve the DG002 data gap
- Clarify regulatory classification: Determine the classification of this product in Taiwan (pharmaceutical drug vs. health supplement vs. food), which will determine the applicable review pathway
- Supplement TFDA product labels and warnings: If relevant products exist, download and parse product labeling PDFs from the FDA website to extract safety information, resolving the DG001 blocking gap
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.